Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
Income from Continuing Operations
Palla Pharma Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Palla Pharma Ltd
ASX:PAL
|
Income from Continuing Operations
-AU$58.8m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
ASX:ADO
|
Income from Continuing Operations
-AU$11.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-19%
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Income from Continuing Operations
-AU$6m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
ASX:CTE
|
Income from Continuing Operations
AU$1.6m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
Genetic Signatures Ltd
ASX:GSS
|
Income from Continuing Operations
-AU$18m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Income from Continuing Operations
AU$3.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's Income from Continuing Operations?
Income from Continuing Operations
-58.8m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Income from Continuing Operations amounts to -58.8m AUD.
What is Palla Pharma Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-19%
Over the last year, the Income from Continuing Operations growth was -368%. The average annual Income from Continuing Operations growth rates for Palla Pharma Ltd have been -71% over the past three years , -19% over the past five years .